Same-Store Revenue and Pricing Momentum
Same-store net revenue for Q4 increased 2.1% year-over-year, driven by a 2.4% increase in net revenue per adjusted admission.
Adjusted EBITDA and Margin Expansion
Q4 adjusted EBITDA was $395 million with a 12.7% margin; adjusted EBITDA was slightly up versus Q4 2024 on a same-store basis and the company achieved the midpoint of updated FY2025 guidance.
Improved Cash Flow and Free Cash Flow Positive
Cash flows from operations were $266 million in Q4 and $543 million for FY2025 (vs. $480 million in 2024). Excluding cash taxes on divestiture gains, adjusted cash flows from operations were $712 million and adjusted free cash flow was $150 million.
Leverage and Balance Sheet Progress
Net leverage improved from 7.4x at year-end 2024 to 6.6x at year-end 2025 and has been further reduced through early 2026 note redemptions; expected net debt after the Huntsville divestiture is ~ $9.2 billion (down from $10.1B YE2025 and $11.4B YE2024).
Material Divestiture Proceeds and Debt Reduction
Completed and pending divestitures generated significant cash (e.g., Clarksville ~ $623M gross, outreach labs ~$152M, contingent $91M) used to redeem high-coupon notes (two $223M redemptions at 103%) and reduce leverage.
Operational & Cost Control Improvements
Sequential adjusted EBITDA margin expansion, controlled labor (average hourly wage growth within expectations and flat contract labor), and 'live' expense down 110 bps YoY to 14.4% of net revenue in Q4 (down 50 bps for FY2025).
Strategic Investments and Service-Line Growth
Targeted market investments produced local wins: ER visits +13% in Knoxville over 2 years after ER expansion; Grandview births +20% (4,000+ babies) after $10M women's services investment; cardiac surgeries +16% in Longview; inbound transfers +~35% in Carlsbad.
Technology Transformation and Early AI Adoption
ERP implementation completed and reportedly saved ~ $50 million in the first year; AI use cases deployed or in rollout include appeals/autonomous coding, virtual patient sitters (reducing safety events), ambient documentation tools, and maternal-fetal early warning systems.